Corcept Therapeutics, Inc. (CORT)
35.39
-1.65
(-4.45%)
USD |
NASDAQ |
Jan 15, 16:00
35.43
+0.04
(+0.11%)
After-Hours: 06:28
Corcept Therapeutics SG&A Expense (TTM): 401.86M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Axsome Therapeutics, Inc. | 514.57M |
| Johnson & Johnson | 23.38B |
| United Therapeutics Corp. | 627.50M |
| Vertex Pharmaceuticals, Inc. | 1.644B |
| Theravance Biopharma, Inc. | 75.94M |